PrEP

Continuing declines in HIV diagnoses thanks to successful PrEP roll-out in NSW

02 Jul 2021

Researchers have revealed the final results of the first study that measured the impact of PrEP on reducing HIV in a large population.

Increased usage and confidence in antiretroviral PrEP for the prevention of HIV found in UNSW study

19 Dec 2019

Significantly more gay and bisexual men are using HIV pre-exposure prophylaxis (PrEP) due to increased confidence in the benefits of HIV treatment for prevention.

Australia will never be HIV-free if access to prevention requires a Medicare card

24 Jan 2019

Eradicating a virus from the community requires everyone to have access to prevention, as is the case with tuberculosis. So why not HIV?

Fewer men who have sex with men are using condoms when taking PrEP, and that's OK

08 Jun 2018

An increase in condomless sex in pre-exposure prophylaxis users is predictable as preventing HIV is the key motivator for condom use among gay and bisexual men.

HIV researchers welcome recommendation to list PrEP on PBS

09 Feb 2018

A recommendation that the HIV prevention drug PrEP be approved for public subsidy has been hailed as an essential step in Australia's response to HIV.

HIV diagnoses in NSW lowest since 1985

23 Aug 2017

The Kirby Institute has been a key player in NSW’s partnership response to HIV, which has reached a historic milestone.

Let’s talk about sex … in the age of PrEP

14 Feb 2017

UNSW researcher Martin Holt will explore the social impacts of rapid changes in HIV prevention when he delivers a free public lecture on 22 February.

Researchers welcome approval of Truvada for HIV prevention

06 May 2016

The Kirby Institute at UNSW has welcomed the Therapeutic Goods Administration's approval of antiretroviral drug Truvada as pre-exposure prophylaxis (PrEP) in Australia.

New trial aims to 'virtually eliminate' new HIV infections in NSW by 2020

01 Dec 2015

A landmark clinical trial led by UNSW researchers aims to halve new HIV infections in NSW within two years and 'virtually eliminate' HIV transmission by 2020.

Kirby Institute launches first of its kind PrEP study

28 Nov 2014

The Kirby Insitute at UNSW has launched a feasibility study to examine whether HIV negative people can take combination drug therapy to reduce their risk of acquiring the virus.